Nasal/buccal midazolam use in the community.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 14709505.
- Also identified by PMC identifier 1755919.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A telephone survey was carried out to evaluate the effectiveness and convenience of nasal/buccal midazolam in terminating prolonged seizures in the community. A total of 33/40 (83%) families who had used it found it effective and easy to use; 20/24 (83%) preferred using midazolam to rectal diazepam.
Medical subject headings
- Anticonvulsants
- Midazolam
- Seizures